ARLINGTON, Va., Feb. 08, 2017 -- Leading healthcare social network Inspire has reached the milestone of one million registered members.
“It’s gratifying and humbling to see the community’s growth,” said Brian Loew, co-founder and CEO of Inspire. “We see it as a testament to the wisdom of empowered patients and caregivers who are leading a movement toward patient-centered care.”
Inspire is known for not just the size of the community but for the activity of the patients and caregivers interacting in more than 200 online groups. Last year, Inspire reached another milestone of one billion words written by its community members.
“The rate at which members are finding and joining Inspire is accelerating exponentially,” said Richard Tsai, VP of marketing at Inspire. “Patients and caregivers across several thousand reported conditions are writing about their experiences, and generating relevant language that others who are facing similar experience can find.”
This sharing of information can be particularly useful for rare disease patients who often have trouble getting an accurate diagnosis, and for cancer patients who are in dire need of support to make the best possible treatment decisions.
Loew noted that Inspire is adding more communities and nonprofit partners regularly. “While we have more improvements planned for our online platform,” he added, “we are committed to ensuring that the focus will continue to be on the wonderful patients and caregivers who share and connect with each other every day in our community.”
About Inspire
Inspire (www.inspire.com) is the patient engagement company. Founded in 2005, Inspire creates and manages health support communities in partnership with over 100 nonprofit organizations, including the American Lung Association, National Psoriasis Foundation, Ovarian Cancer Research Fund Alliance, the Arthritis Foundation, and the Alzheimer's Foundation of America. Inspire works with its pharmaceutical clients to help them explore engagement and insight opportunities with these highly engaged populations of patients. Inspire helps companies integrate patient-centricity into the pharmaceutical product lifecycle, from clinical trial design and recruitment to post-marketing brand/unbranded activities.
Contact: John Novack Inspire (800) 945-0381 [email protected]


Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 



